NYSEARCA:BOUT - Innovator IBD Breakout Opportunities ETF Stock Price, News & Analysis

$20.17
+0.13 (+0.65 %)
(As of 09/19/2019 03:02 PM ET)
Add
Today's Range
$20.08
Now: $20.1657
$20.17
50-Day Range
$19.56
MA: $20.92
$21.75
52-Week Range
$16.26
Now: $20.1657
$24.98
Volume922 shs
Average Volume7,135 shs
Market Capitalization$9.07 million
P/E RatioN/A
Dividend Yield0.20%
BetaN/A

Basic Details

Issuer Innovator Capital Management
Fund NameInnovator IBD Breakout Opportunities ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:BOUT
Inception Date9/13/2018
Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkIBD Breakout Stocks Index
CategoryBroad Equity
FocusBroad Equity
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$9.05 million
Average Daily Volume$5,193.00
Discount/Premium-0.07%

ETF Expenses

Management Fee0.80%
Other Expenses0.00%
Total Expenses0.80%
Fee Waiver0.00%
Net Expenses0.80%

Administrator, Advisor and Custodian

AdministratorUS Bancorp Fund Services LLC
AdvisorInnovator Capital Management, LLC
CustodianU.S. Bank, N.A.
DistributorForeside Fund Services, LLC
Transfer AgentUS Bancorp Fund Services LLC
Trustee
Lead Market Maker

Receive BOUT News and Ratings via Email

Sign-up to receive the latest news and ratings for BOUT and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)
Currency Exposure of Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)
Sector Exposure of Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)
Industry Exposure of Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Frequently Asked Questions

What is Innovator IBD Breakout Opportunities ETF's stock symbol?

Innovator IBD Breakout Opportunities ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BOUT."

How often does Innovator IBD Breakout Opportunities ETF pay dividends? What is the dividend yield for Innovator IBD Breakout Opportunities ETF?

Innovator IBD Breakout Opportunities ETF announced a special dividend on Thursday, December 27th. Shareholders of record on Friday, December 28th will be given a dividend of $0.0389 per share on Wednesday, January 2nd. The ex-dividend date is Thursday, December 27th. View Innovator IBD Breakout Opportunities ETF's Dividend History.

Has Innovator IBD Breakout Opportunities ETF been receiving favorable news coverage?

Media stories about BOUT stock have been trending negative on Thursday, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Innovator IBD Breakout Opportunities ETF earned a daily sentiment score of -2.9 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Innovator IBD Breakout Opportunities ETF.

Who are Innovator IBD Breakout Opportunities ETF's major shareholders?

Innovator IBD Breakout Opportunities ETF's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Susquehanna International Group LLP (3.24%), First Allied Advisory Services Inc. (2.60%) and F3Logic LLC (2.11%).

Which major investors are buying Innovator IBD Breakout Opportunities ETF stock?

BOUT stock was purchased by a variety of institutional investors in the last quarter, including Susquehanna International Group LLP, First Allied Advisory Services Inc. and F3Logic LLC.

How do I buy shares of Innovator IBD Breakout Opportunities ETF?

Shares of BOUT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Innovator IBD Breakout Opportunities ETF's stock price today?

One share of BOUT stock can currently be purchased for approximately $20.1657.

How big of a company is Innovator IBD Breakout Opportunities ETF?

Innovator IBD Breakout Opportunities ETF has a market capitalization of $9.07 million. View Additional Information About Innovator IBD Breakout Opportunities ETF.


MarketBeat Community Rating for Innovator IBD Breakout Opportunities ETF (NYSEARCA BOUT)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  7 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  12
MarketBeat's community ratings are surveys of what our community members think about Innovator IBD Breakout Opportunities ETF and other stocks. Vote "Outperform" if you believe BOUT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BOUT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/19/2019 by MarketBeat.com Staff

Featured Article: LIBOR

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel